From killers to strategists: CAR T cells enter their multifunctional era

https://www.news-medical.net/news/20260430/From-killers-to-strategists-CAR-T-cells-enter-their-multifunctional-era.aspx A sweeping trial landscape review shows how CAR T therapy is moving beyond one-target designs toward multifunctional “living drugs” designed to improve safety, overcome tumor escape, and tackle harder-to-treat cancers.